Turn Therapeutics Appoints Andrew Scott as VP of Corporate Communications

Turn Therapeutics Inc.

Andrew Scott appointed VP of Corporate Communications effective November 4, 2025.
Scott will oversee IR, capital markets strategy, and licensing partnerships.
He joins from ThinkEquity LLC, where he was Managing Director of Investment Banking.
Scott has helped raise approximately $3 billion across life-sciences transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.